We recently compiled a list of the Top 10 AI-Powered Biotech Stocks to Buy Right Now. Tyra Biosciences, Inc. is one of the ...
IDEAYA Biosciences, Inc. (IDYA) PT Increased as Wedbush Highlights Positive OptimUM-02 Trial Readout
We recently compiled a list of the Top 10 AI-Powered Biotech Stocks to Buy Right Now. IDEAYA Biosciences, Inc. is among the best biotech stocks to invest in. TheFly reported on April 14 that Wedbush ...
View Artelo Biosciences Inc ARTL stock quote prices, financial information, real-time forecasts, and company news from CNN.
On April 9, Niagen Bioscience Inc. (NASDAQ:NAGE) announced that Nicotinamide Riboside Chloride, the patented form of ...
Zacks Investment Research on MSN
Arcus Biosciences (RCUS) moves 7.8% higher: Will this strength last?
Arcus Biosciences, Inc. (RCUS) shares ended the last trading session 7.8% higher at $24.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...
Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation™ (nsPFA™) energy, today announced that its nPulse™ Cardiac Catheter will be ...
Artelo Biosciences, Inc. ARTL shares jumped on Monday after the company announced the publication of a peer‑reviewed article ...
Pulse Biosciences, Inc. (NASDAQ:PLSE) is one of the must-buy small cap stocks to buy. On April 7, Pulse Biosciences, Inc.
In September 2025, the Company launched AboutNAD®, a next-generation digital platform designed to serve as the leading online resource for scientific advancements in NAD+ research and healthy aging.
“Niagen IV is now offered at over 900 clinics nationwide, including the new iCRYO locations,” stated Rob Fried, CEO of Niagen Bioscience. “This milestone highlights the growing recognition of Niagen ...
Octave Bioscience, Inc. is a commercial stage precision care company pioneering biomarker-driven solutions for neurodegenerative diseases, with initial focus on Multiple Sclerosis, and Parkinson’s ...
Harvard Bioscience, a life science equipment manufacturer based in Holliston, reported a net loss of $410,000 for the company’s second quarter financials in an earnings report released on Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results